<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=US-ASCII">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: Re: HOLEY Fullerenes, Batman!</title>
<meta name="Author" content="Robert J. Bradbury (bradbury@aeiveos.com)">
<meta name="Subject" content="Re: HOLEY Fullerenes, Batman!">
<meta name="Date" content="2003-06-17">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>Re: HOLEY Fullerenes, Batman!</h1>
<!-- received="Tue Jun 17 07:28:36 2003" -->
<!-- isoreceived="20030617132836" -->
<!-- sent="Tue, 17 Jun 2003 06:28:35 -0700 (PDT)" -->
<!-- isosent="20030617132835" -->
<!-- name="Robert J. Bradbury" -->
<!-- email="bradbury@aeiveos.com" -->
<!-- subject="Re: HOLEY Fullerenes, Batman!" -->
<!-- id="Pine.LNX.4.44.0306170615050.29822-100000@server.aeiveos.com" -->
<!-- charset="US-ASCII" -->
<!-- inreplyto="00ec01c334cb$c5a77f80$6fc58ec6@brett" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Robert J. Bradbury (<a href="mailto:bradbury@aeiveos.com?Subject=Re:%20HOLEY%20Fullerenes,%20Batman!"><em>bradbury@aeiveos.com</em></a>)<br>
<strong>Date:</strong> Tue Jun 17 2003 - 07:28:35 MDT
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="10407.html">Harvey Newstrom: "RE: META: Time to enforce the List Rules!  (personal revelation)"</a>
<ul>
<li><strong>Previous message:</strong> <a href="10405.html">Robert J. Bradbury: "RE: greatest threats to survival (was: why believe the truth?)"</a>
<li><strong>In reply to:</strong> <a href="10402.html">Brett Paatsch: "Re: HOLEY Fullerenes, Batman!"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="10417.html">Brett Paatsch: "Finding cancer cell markers? (was Re: HOLEY Fullerenes, Batman!)"</a>
<li><strong>Reply:</strong> <a href="10417.html">Brett Paatsch: "Finding cancer cell markers? (was Re: HOLEY Fullerenes, Batman!)"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#10406">[ date ]</a>
<a href="index.html#10406">[ thread ]</a>
<a href="subject.html#10406">[ subject ]</a>
<a href="author.html#10406">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
On Tue, 17 Jun 2003, Brett Paatsch wrote:
<br>
<p><em>&gt; What would be neat would be if we could find some natty way of getting
</em><br>
<em>&gt; nanoparticles containing cytotoxins directed in on monoclonal quantum dot
</em><br>
<em>&gt; labelled tumor sites. It would give us a nice way of doing cell specific
</em><br>
<em>&gt; chemotherapy with less side effects.
</em><br>
<p>Brett, I think one of the problems here is that one may not have good,
<br>
reliable markers for most tumors types.  Without them it is difficult to
<br>
produce a reliable monoclonal.  If you did have the markers radiolabeled
<br>
monoclonals would be further along than they seem to be.  There are a few
<br>
of these that may be being worked on in the clinical setting but because
<br>
the number of things that can go wrong to produce cancer one has a real
<br>
problem of needing to know what exactly what sub-type of cancer it is
<br>
(that is why Gleevec tends to be so effective -- it is a very mutation
<br>
specific type of cancer).  Some sub-types, perhaps many, are unlikely
<br>
to display a molecule on the cell surface that identifies itself as
<br>
that sub-type.  That is why there is an emphasis on angiogenesis
<br>
inhibitors -- all sub-types are sooner or later going to need an
<br>
expanded blood supply to grow.
<br>
<p>Robert
<br>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="10407.html">Harvey Newstrom: "RE: META: Time to enforce the List Rules!  (personal revelation)"</a>
<li><strong>Previous message:</strong> <a href="10405.html">Robert J. Bradbury: "RE: greatest threats to survival (was: why believe the truth?)"</a>
<li><strong>In reply to:</strong> <a href="10402.html">Brett Paatsch: "Re: HOLEY Fullerenes, Batman!"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="10417.html">Brett Paatsch: "Finding cancer cell markers? (was Re: HOLEY Fullerenes, Batman!)"</a>
<li><strong>Reply:</strong> <a href="10417.html">Brett Paatsch: "Finding cancer cell markers? (was Re: HOLEY Fullerenes, Batman!)"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#10406">[ date ]</a>
<a href="index.html#10406">[ thread ]</a>
<a href="subject.html#10406">[ subject ]</a>
<a href="author.html#10406">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Tue Jun 17 2003 - 07:38:29 MDT
</em></small></p>
</body>
</html>
